AVY
60
6
CLX
50
-3
FRT
60
2
COST
47
-3
EIX
56
2
SPG
58
3
QRVO
46
-2
SWK
58
-3
HSY
41
6
CRM
50
-9
ICE
64
-3
EMR
67
2
CF
48
-2
ZTS
17
5
TDC
76
-7
AAL
54
3
GOOG
71
-2
TGNA
56
-2
NVDA
49
2
WHR
55
-2
AVY
60
6
CLX
50
-3
FRT
60
2
COST
47
-3
EIX
56
2
SPG
58
3
QRVO
46
-2
SWK
58
-3
HSY
41
6
CRM
50
-9
ICE
64
-3
EMR
67
2
CF
48
-2
ZTS
17
5
TDC
76
-7
AAL
54
3
GOOG
71
-2
TGNA
56
-2
NVDA
49
2
WHR
55
-2
Financhill
Back

John Hancock Tax- Advantaged Dividend Income Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Buy
68

HTD
John Hancock Tax- Advantaged Dividend Income

Last Price:
$23.49
Seasonality Move:
-0.31%
Sell
33

ZBIO
Zenas BioPharma, Inc.

Last Price:
$36.94
Seasonality Move:
-8.13%
Buy
68
John Hancock Tax- Advantaged Dividend Income (HTD) is a Buy

Is John Hancock Tax- Advantaged Dividend Income a Buy, Sell or Hold?

  • The current John Hancock Tax- Advantaged Dividend Income [HTD] share price is $23.62. The Score for HTD is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • HTD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Zenas BioPharma, Inc. (ZBIO) is a Sell

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $32.59. The Score for ZBIO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • ZBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HTD Stock Price Chart

What is John Hancock Tax- Advantaged Dividend Income's stock price today?

  • The John Hancock Tax- Advantaged Dividend Income share price today is $23.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HTD is experiencing selling pressure, which indicates risk of future bearish movement.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $32.59
    The current trend is moderately bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

HTD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 34.22 Sell
Chaikin Money Flow: -75378 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.39 Buy
Relative Strength Index (14 RSI): 42.51 Sell
Chaikin Money Flow: -433025 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

HTD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.14 Sell
20-day SMA: 24.27 Sell
50-day SMA: 24.6 Sell
200-day SMA: 23.76 Sell
8-day EMA: 24.03 Sell
20-day EMA: 24.27 Sell
50-day EMA: 23.96 Sell
200-day EMA: 15.23 Buy

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.44 Sell
20-day SMA: 37.66 Sell
50-day SMA: 32.27 Buy
200-day SMA: 17.45 Buy
8-day EMA: 37.61 Sell
20-day EMA: 34.32 Sell
50-day EMA: 23.15 Buy
200-day EMA: 7.97 Buy

John Hancock Tax- Advantaged Dividend Income Earnings Growth & HTD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.

John Hancock Tax- Advantaged Dividend Income Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):